Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] LIG D&A (079550) – iM Securities | Export Pipeline · CapEx & Hiring Expansion · Global Air Defense Growth / 2026-08-07 Research
  • [Research] Samsung SDI (006400) – DS Investment & Securities | 4Q Turnaround Visibility · Non-PFE LFP ESS · European Volume Models / 2026-04-29 Research
  • [Research] LIG D&A (079550) – DS Investment & Securities | Order Expansion · Iraq Cheongung-II Mass Production · Long-term Earnings Growth / 2026-08-07 Research
  • [Research] Samsung SDI (006400) – iM Securities | Surging AIDC ESS Demand · US Regulatory Tailwinds · Valuation Assessment / 2026-04-29 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | 1Q Trough Passing · ESS Utilization Gains · Humanoid Client Expansion / 2026-03-30 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | Gradual Loss Narrowing · Solid-State Battery Development Pipeline · Robotics Partnerships / 2026-02-03 Research
  • [Research] Celltrion (068270) – Shinhan Securities | New Product Sales Expansion · Operating Leverage · Global CMO Contracts / 2026-05-15 Research

[Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16

Posted on March 16, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Daishin Securities

Analyst : Hyungkeun Ryu, RA Jiwon Seo

Investment Rating : BUY (Maintained)

Target Price : 1,450,000 KRW (Maintained)

Core Momentum : Sharp DRAM and NAND ASP increases are expected to drive a significant Q1 earnings beat and substantial full-year earnings upgrades, while the recent share-price correction leaves valuation at an attractive level relative to improving fundamentals.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price / Investment Rating: 1,450,000 KRW / BUY (Maintain)
  • Current Price (as of 26.03.13): 910,000 KRW
  • Market Capitalization: 648,559 billion KRW (KOSPI 5487.24pt)
  • Key Financial Metrics (2023A / 2024A / 2025F / 2026F / 2027F):
    • Revenue: 32,766 billion KRW / 66,193 billion KRW / 97,147 billion KRW / 275,630 billion KRW / 311,971 billion KRW
    • Operating Profit: -7,730 billion KRW / 23,467 billion KRW / 47,206 billion KRW / 204,009 billion KRW / 206,101 billion KRW
    • Net Income Attributable to Controlling Interests: -9,112 billion KRW / 19,789 billion KRW / 42,919 billion KRW / 155,938 billion KRW / 157,544 billion KRW
    • EPS: -12,517 KRW / 27,182 KRW / 58,955 KRW / 218,298 KRW / 221,062 KRW
    • PER: NA / 6.4x / 11.0x / 4.3x / 4.2x
    • PBR: 1.9x / 1.7x / 5.5x / 2.4x / 1.5x
    • ROE: -15.6% / 31.1% / 44.2% / 78.9% / 44.7%

🚀 2. [Market Opportunities & Business Outlook]

  • Upward Revision of 2026 Earnings Outlook: The operating profit estimate for 2026 has been revised upward from 174 trillion KRW to 204 trillion KRW. Situated in a remarkably undervalued zone with ample catalysts for a rebound, an aggressive buying approach is warranted.
  • 1Q26 Preview (Earnings Surprise): First-quarter revenue is projected at 52.6 trillion KRW (+60% QoQ, +198% YoY) and operating profit at 38.0 trillion KRW (OPM +72.3%), outperforming consensus estimates (revenue of 47.5 trillion KRW and operating profit of 32.2 trillion KRW). Potent pricing gains (1Q26 ASP: DRAM +62% QoQ, legacy DRAM +95% QoQ, NAND +60% QoQ) will drive company-wide profit expansion.
  • Key Investment Catalysts:
    1. Micron Earnings Release: Ahead of Micron Technology’s earnings announcement, concrete evidence of an intense super-cycle is expected to intensify market focus on SK hynix.
    2. GTC 2026 & NAND Growth: GTC 2026 will serve as an event amplifying optimism for the NAND market, showcasing AI server storage innovations like HBF and Solidigm-backed QLC strengths.
    3. Enhanced Shareholder Returns: Strengthened dividend policies and concrete plans for an ADR issuance are anticipated.

📝 Editor’s Comment (Perspective)

The analyst evaluates that despite the drop in stock price due to macroeconomic risks, the 2026 operating profit forecast has been revised upward and robust ASP growth continues, while valuation remains in a remarkably undervalued zone. This perspective emphasizes focusing on fundamental improvement and earnings visibility despite short-term volatility.

To determine whether this investment thesis is unfolding as projected, key items to monitor include the realization of the projected 38 trillion KRW operating profit for Q1, confirmation of industry strength through Micron’s earnings report, and progress on ADR issuance plans and shareholder return initiatives. These developments can be tracked through upcoming quarterly and annual earnings releases, official corporate IR materials, and regulatory disclosures via DART/KRX.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04
Next Post: [Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18

Related Posts

  • [Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18 Research
  • [Research] Hanwha Ocean (042660) – Eugene | High-Price Order Mix · Merchant Margin Continuity · Special Ship Pipeline / 2026-07-28 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Clinical Data · Pipeline Progress · Tech Transfer / 2026-05-21 Research
  • [Research] Alteogen (196170) – Shinhan Securities | Keytruda SC Growth Accelerates · Favorable Contract Terms · Early June PGR Catalysts / 2026-05-11 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | 4Q25 Review · Conservative 2026E Guidance · Long-term Structural Growth / 2026-02-19 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ROE Expansion · Net Cash · Shareholder Returns / 2026-07-29 Research
  • [Research] LIG D&A (079550/KS) – SK Securities | 1Q26 Earnings Beat · Overdone Correction · Global Demand Expansion / 2026-05-08 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Profit Turnaround · ESS Margin Support · North America LFP Ramp-up / 2026-07-20 Research
  • [Research] Alteogen (196170) – Daishin Securities | Validated ALT-B4 Platform · Keytruda SC Milestones Accelerate · Coverage Initiation / 2026-05-19 Research
  • [IR] Samsung Electronics (005930) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [IR] SK hynix (000660 / SKHY) – Q1 2024 Earnings Presentation / 2024-04-25 IR Room
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | LTA Transition · Specialty MLCC · Valuation Re-rating / 2026-07-01 Research
  • [Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme